Global Sexually Transmitted Diseases (STD) Testing Market, By Disease Type (Chlamydia, Syphilis, Gonorrhea, Herpes Simplex Virus, Human Papilloma Virus, Human Immunodeficiency Virus, Other), Location of Testing (Laboratory Testing, Point of Care (POC) Testing), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029.
Market Analysis and Insights of Sexually Transmitted Diseases (STD) Testing Market
Data Bridge Market Research analyses that the sexually transmitted diseases (STD) testing market to account USD 1,58,734.55 million by 2029 growing at a CAGR of 7.85% in the forecast period of 2022-2029. Increasing cases of gonorrhoea and chlamydia and rising public awareness about sexually transmitted disease are the factors which will create new opportunities for the sexually transmitted disease testing market in the forecast period.
Sexually transmitted diseases are those that are passed on through sexual contact. Sexually transmitted diseases can also be transmitted through breastfeeding, birth, and shared needle use in some cases.
Important factors driving the growth of the sexually transmitted diseases (STD) testing market include increased public awareness and patient education. Furthermore, the rise in sexually transmitted diseases prevalence globally, increased patient awareness through education campaigns, and a surge in government initiatives are expected to drive market growth. In the last decade, there has been a significant increase in the prevalence and incidence of sexually transmitted diseases. As the prevalence of sexually transmitted diseases rises, countries around the world are focusing on the implementation of national screening programmes to increase the coverage of sexually transmitted diseases diagnosis. Furthermore, reimbursement policies for sexually transmitted diseases services have been favourable. These factors are significantly driving the global sexually transmitted diseases testing market's growth.
Technological advancements and advancements in sexually transmitted diseases diagnosis are also expected to drive market growth. Increased implementation of national screening programmes to improve sexually transmitted diseases diagnosis coverage will also expand the sexually transmitted diseases testing market.
Lack of patient awareness is likely to hamper the growth of the sexually transmitted diseases (STD) testing market during the forecast period. The side effects of these medications are less severe than those of other treatments. Infection, on the other hand, is a serious constraint. Overdoes of analgesic post-operative pain medication, in particular, are causing a high death rate. These medications are not appropriate for the majority of patients. These factors are limiting the decline and patient interest in these devices.
This sexually transmitted diseases (STD) testing market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on sexually transmitted diseases (STD) testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Sexually Transmitted Diseases (STD) Testing Market Scope and Market Size
STD testing market is segmented of the basis of disease type and location of testing. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of disease type, the sexually transmitted diseases (STD) testing market is segmented into chlamydia, syphilis, gonorrhea, herpes simplex virus, human papilloma virus, human immunodeficiency virus, and other.
- The sexually transmitted diseases (STD) testing market is also segmented on the basis of location of testing. The location of testing segment is further divided into laboratory testing and point of care (POC) testing.
.Sexually Transmitted Diseases (STD) Testing Market Country Level Analysis
The sexually transmitted diseases (STD) testing market is analysed and market size insights and trends are provided by country, disease type and location of testing as referenced above.
The countries covered in the sexually transmitted diseases (STD) testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Asia-Pacific dominated the market accounting for the largest share, and this trend is expected to continue throughout the forecast period. This is due to an increase in the number of cases of sexually transmitted diseases in developing countries. Furthermore, increased patient awareness through education campaigns and expanding government initiatives are expected to drive the sexually transmitted diseases testing market growth.
The country section of the sexually transmitted diseases (STD) testing market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The sexually transmitted diseases (STD) testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for sexually transmitted diseases (STD) testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the sexually transmitted diseases (STD) testing market. The data is available for historic period 2010 to 2020.
Competitive Landscape and Sexually Transmitted Diseases (STD) Testing Market Share Analysis
The sexually transmitted diseases (STD) testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to sexually transmitted diseases (STD) testing market.
Some of the major players operating in the sexually transmitted diseases (STD) testing market are bioMérieux SA, BD, Hologic, Inc., OraSure Technologies, Inc., Bio-Rad Laboratories, Inc., Abbott. Merck & Co. Inc., Johnson & Johnson Services, Inc, GlaxoSmithKline Plc., Allergen, Bayer AG, Bristol-Myers Squibb Company, Bausch Health Companies Inc., Boehringer Ingelheim International GmbH, Sorrento Therapeutics, Inc., WEX Pharmaceuticals Inc., Zynerba Pharmaceuticals, Inc., Medtronic, Boston Scientific Corporation, Halyard Health, Inc. and Neurotech Na, Inc. among others.
SKU-